West Pharmaceutical Services Opens 165,000 Sq Ft Dublin Expansion for Injectable Therapies
West Pharmaceutical Services opened a 165,000 sq ft expansion at its Damastown, Dublin site to boost contract manufacturing capacity for high-volume injectable therapies such as diabetes and obesity treatments. The new facility adds advanced automation and commercial-scale drug handling capabilities integrated through its West Vantage development-to-commercialization services.
1. Dublin Facility Expansion
West has inaugurated a 165,000 sq ft facility at its existing Damastown, Dublin campus. This expansion is designed to meet surging global demand for high-volume injectable treatments.
2. Advanced Manufacturing and Automation
The new site incorporates advanced automation, large-scale drug handling systems, component molding, device assembly and packaging at commercial scale. These upgrades enhance contract capabilities across the development lifecycle.
3. Strategic Impact on Injectable Supply
Operating under West Vantage, the Dublin expansion integrates conceptualization, development, manufacturing, analytical testing and regulatory support. This strengthens West’s role in supplying diabetes, obesity and next-generation GLP-1 therapies and accelerates customer time to market.